ZATTONI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.900
AS - Asia 9.790
EU - Europa 4.324
SA - Sud America 1.880
AF - Africa 1.621
OC - Oceania 155
Continente sconosciuto - Info sul continente non disponibili 72
AN - Antartide 1
Totale 29.743
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.947
SG - Singapore 2.984
CN - Cina 1.700
VN - Vietnam 1.526
BR - Brasile 1.228
IT - Italia 1.024
HK - Hong Kong 956
FR - Francia 374
DE - Germania 316
IN - India 304
PL - Polonia 277
FI - Finlandia 275
NL - Olanda 220
GB - Regno Unito 192
RU - Federazione Russa 172
TR - Turchia 159
IQ - Iraq 142
AR - Argentina 141
BD - Bangladesh 141
JP - Giappone 137
MX - Messico 127
ID - Indonesia 123
CA - Canada 120
ES - Italia 118
KR - Corea 110
SE - Svezia 109
PH - Filippine 105
PK - Pakistan 104
SA - Arabia Saudita 101
ZA - Sudafrica 90
UZ - Uzbekistan 89
BJ - Benin 86
EC - Ecuador 85
AT - Austria 83
IE - Irlanda 76
CH - Svizzera 72
UA - Ucraina 69
CO - Colombia 68
JO - Giordania 68
VE - Venezuela 68
CI - Costa d'Avorio 60
LB - Libano 60
PY - Paraguay 59
AE - Emirati Arabi Uniti 58
IR - Iran 58
PE - Perù 58
NP - Nepal 57
EG - Egitto 56
KG - Kirghizistan 56
MY - Malesia 56
AL - Albania 55
MA - Marocco 55
NI - Nicaragua 54
CL - Cile 52
GT - Guatemala 52
TN - Tunisia 52
DO - Repubblica Dominicana 51
ET - Etiopia 51
KE - Kenya 51
RS - Serbia 51
GR - Grecia 49
PS - Palestinian Territory 49
TH - Thailandia 49
BE - Belgio 48
LA - Repubblica Popolare Democratica del Laos 48
SK - Slovacchia (Repubblica Slovacca) 48
BG - Bulgaria 47
CR - Costa Rica 47
DZ - Algeria 47
BY - Bielorussia 46
KZ - Kazakistan 46
LV - Lettonia 46
PA - Panama 46
TJ - Tagikistan 46
YT - Mayotte 46
AU - Australia 45
HN - Honduras 45
MU - Mauritius 45
UY - Uruguay 45
IL - Israele 44
ML - Mali 44
NO - Norvegia 44
CV - Capo Verde 43
AO - Angola 42
JM - Giamaica 42
CZ - Repubblica Ceca 41
GA - Gabon 41
HU - Ungheria 41
KH - Cambogia 41
AZ - Azerbaigian 40
BZ - Belize 40
BW - Botswana 39
CD - Congo 39
GE - Georgia 39
IS - Islanda 39
BO - Bolivia 38
CY - Cipro 38
GF - Guiana Francese 38
BS - Bahamas 37
CU - Cuba 37
Totale 27.923
Salva come PNG Salva come JPEG
Città #
Singapore 1.787
Ashburn 1.506
San Jose 1.381
Fairfield 1.199
Hong Kong 835
Woodbridge 538
Chandler 474
Seattle 446
Houston 437
Ho Chi Minh City 421
Cambridge 387
Wilmington 377
Hanoi 328
Santa Clara 319
Ann Arbor 317
Beijing 278
Los Angeles 247
Boardman 216
Bytom 185
Dong Ket 185
Helsinki 175
Lauterbourg 164
New York 160
Council Bluffs 141
San Diego 140
Princeton 119
Medford 117
Munich 112
São Paulo 110
Padova 107
Hefei 105
Guangzhou 102
Des Moines 95
Milan 95
Tokyo 83
Da Nang 81
Cotonou 80
Tashkent 79
Orem 74
Chicago 73
Buffalo 65
Amman 64
Seoul 64
Dublin 61
Warsaw 60
Abidjan 57
Haiphong 57
Rome 57
Roxbury 57
The Dalles 56
Managua 52
Baghdad 51
Nanjing 49
Shanghai 49
Montreal 47
Addis Ababa 45
Nairobi 45
Rio de Janeiro 45
Bamako 44
Chennai 44
Johannesburg 43
Panama City 43
Vienna 43
Dallas 42
Denver 42
Dushanbe 41
Istanbul 41
Vientiane 41
Bishkek 40
Libreville 40
Lima 40
Montevideo 39
Phnom Penh 39
Frankfurt am Main 38
Riga 38
Luanda 37
Conakry 36
Dakar 36
Nassau 36
Praia 36
Stockholm 36
Turku 36
Baku 34
Castries 34
Harare 34
Jakarta 34
Jeddah 34
Zurich 34
Accra 33
Nuremberg 33
Guatemala City 32
Lahore 32
London 32
Paris 32
Reykjavik 32
Amsterdam 31
Bridgetown 31
Havana 31
Kampala 31
Lappeenranta 31
Totale 16.592
Salva come PNG Salva come JPEG
Nome #
A 10-year history of secondary hypertension: A challenging case of renin-secreting juxtaglomerular cell tumor 386
The Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy 326
The value of open conversion simulations during robot-assisted radical prostatectomy: Implications for robotic training curricula 316
Complex cystine kidney stones treated with combined robot-assisted laparoscopic pyelolithotomy and intraoperative renoscopy 312
Technical innovations to optimize continence recovery after robotic assisted radical prostatectomy 306
10-Year Clinical Experience with 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 Patients 304
Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study 292
Development of a Surgical Safety Training Program and Checklist for Conversion during Robotic Partial Nephrectomies 281
Fluorocholine PET/CT predicts skeletal progression, skeletal event and cancer specific survival in patients with biochemical relapse for prostate cancer 272
Spermatic Cord Sarcoma: Our Experience and Review of the Literature 247
PET/MRI in prostate cancer: a systematic review and meta-analysis 247
18F-fluoromethylcholine or 18F-fluoroethylcholine pet for prostate cancer imaging: Which is better? A literature revision 245
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 245
Histopathological characteristics of microfocal prostate cancer detected during systematic prostate biopsy. 240
Effect of allogeneic intraoperative blood transfusion on survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution 229
The effects of androgen deprivation therapy on the 18F-choline uptake in prostate cancer patients undergoing neoadjuvant treatment 229
The impact of COVID-19 pandemic on pornography habits: a global analysis of Google Trends 229
MP55-05 PARTIAL NEPHRECTOMY IN THE TREATMENT OF RENAL TUMORS WITH CONCOMITANT VENOUS TUMOR THROMBOSIS (VTT) OF RENAL VEIN BRANCHES: RETROSPECTIVE, MULTI-CENTER ANALYSIS OF PERIOPERATIVE, FUNCTIONAL, AND ONCOLOGIC OUTCOMES 226
MP59-08 EXTERNAL VALIDATION OF RENAL TUMOUR CONTACT SURFACE AREA (CSA) IN PATIENTS WHO UNDERWENT PARTIAL NEPHRECTOMY 225
Urinary microbiome and urological cancers: a mini review 222
Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy 221
Key strategies for reducing recurrence in T1 bladder cancer. Evidence from a retrospective multicenter European study 220
Endourologic Diagnosis and Robotic Treatment of a Giant Fibroepithelial Polyp of the Ureter 217
Early detection of prostate cancer relapse by biochemistry and diagnostic imaging 216
Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coil 216
Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [18F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis 216
Global minimally invasive pyeloplasty study in children: Results from the Pediatric Urology Expert Group of the European Association of Urology Young Academic Urologists working party 216
Wunderlich's syndrome: three cases of acute spontaneous renal bleeding, conservatively treated. 215
Ultrasound-guided transversus abdominis plane block (US-TAPb) for robot-assisted radical prostatectomy: a novel ‘4-point’ technique—results of a prospective, randomized study 214
An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsy 211
Thyroid-like follicular carcinoma of the kidney: report of two cases with detailed immunohistochemical profile and literature review. 211
MRI-derived PRECISE score for predicting pathologically-confirmed progression in prostate cancer patients on active surveillance 209
Perioperative outcomes and early survival in octogenarians who underwent radical cystectomy for bladder cancer 209
Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial. 208
Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis. 207
The Endourological Treatment of Renal Matrix Stones 205
Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT 205
Perioperative, Oncological, and Functional Outcomes of New Multiport Robotic Platforms in Urology: A Systematic Review and Meta-analysis 202
Should radical prostatectomy be encouraged at any age? A critical non-systematic review 200
THE ENDOUROLOGICAL TREATMENT OF RENAL MATRIX STONES 197
Retzius-sparing Robot-assisted Simple Prostatectomy: Perioperative and Short-term Functional Outcomes Assessed via Validated Questionnaires 195
Navigating the evolving diagnostic and therapeutic landscape of low- and intermediate-risk prostate cancer 193
Combined robotic-assisted retroperitoneoscopic partial nephrectomy and extraperitoneal prostatectomy. First case reported. 193
PD19-01 THE VALUE OF OPEN CONVERSION SIMULATIONS DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY: IMPLICATIONS FOR ROBOTIC TRAINING CURRICULUMS 192
68Ga-dotatoc vs.18F-FDG vs. radiolabelled PSMA PET/CT in renal cancer patients 191
MP79-02 EVALUATION OF THE PROGNOSTIC IMPACT OF 18F-CHOLINE PET/CT IN PATIENTS WITH SKELETAL RECURRENCE PROSTATE CANCER 190
Oncologic Outcomes of Incidental Versus Biopsy-diagnosed Grade Group 1 Prostate Cancer: A Multi-institutional Study 189
A Prospective Randomized Multicenter Study on the Impact of [18F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer 189
Can 68GA-PSMA or radiolabeled choline PET/CT guide salvage lymph node dissection in recurrent prostate cancer? 188
RETROGRADE INTRA RENAL SURGERY FOR RENAL STONES 188
Metabolic syndrome and prostate cancer treatment 188
PD36-03 PERIOPERATIVE OUTCOMES OF OPEN RADICAL CYSTECTOMY IN OCTOGENARIANS: RESULTS FROM TWO HIGH-VOLUME CENTRES 187
Minimally invasive urologic surgery is safe during COVID-19: experience from two high-volume centers in Italy 186
Metabolic syndrome and stone disease 183
Multimodal treatment for high-risk locally-advanced prostate cancer following radical prostatectomy and extended lymphadenectomy 181
Diagnosis of clinically significant prostate cancer after negative multiparametric magnetic resonance imaging 180
Correlation between pathologic features and perfusion CT of renal cancer: a feasibility study. 180
Why and How to Evaluate Chronic Prostatic Inflammation 180
Radiolabelled choline and FDG PET/CT: two alternatives for the assessment of lymph node metastases in patients with upper urinary tract urothelial carcinoma 179
Prostate cancer: more effective use of underutilized postoperative radiation therapy 179
Relevance of the Endoscopic Evaluation in the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis 176
Efficacy and safety of antegrade sclerotherapy for varicocele in pediatric patients: A systematic review 175
PD11-01 COMPARISON BETWEEN THE DIAGNOSTIC ACCURACIES OF 18F-FLUORODEOXYGLUCOSE (FDG) POSITRON EMISSION TOMOGRAPHY (PET)/COMPUTED TOMOGRAPHY (CT) AND MORPHOLOGICAL IMAGING IN RECURRENT UROTHELIAL CARCINOMAS: A RETROSPECTIVE, MULTI-CENTER STUDY 175
Study Protocol for the DETECTIVE Study: An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer 174
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study 173
Early detection of prostate cancer relapse by biochemistry and diagnostic imaging 173
THE ENDOUROLOGICAL TREATMENT OF RENAL MATRIX STONES 172
Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomized, Multicenter Study. Lancet 2020;395:1208–16 172
Re: Evelien J.E. van Altena, Bernard H.E. Jansen, Marieke L. Korbee, et al. Prostate-specific Membrane Antigen Positron Emission Tomography Before Reaching the Phoenix Criteria for Biochemical Recurrence of Prostate Cancer After Radiotherapy: Earlier Detection of Recurrences. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2024.09.015 171
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography 171
Transitional cell carcinoma recurrence impacting intestinal diversion after radical cystectomy. Oncologic outcomes of a rare site of recurrence 171
Is "extreme" bladder neck preservation in robot-assisted radical prostatectomy a safe procedure? 168
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study) 166
ULTRASOUND DETECTED NON-PALPABLE TESTICULAR LESIONS: WHAT DO YOU DO? 165
Role of radiomic analysis of [18F]fluoromethylcholine PET/CT in predicting biochemical recurrence in a cohort of intermediate and high risk prostate cancer patients at initial staging 164
Risk stratification for benign prostatic hyperplasia 163
Utility of Choline Positron Emission Tomography/Computed Tomography for Lymph Node Involvement Identification in Intermediate- to High-risk Prostate Cancer: A Systematic Literature Review and Meta-analysis. 162
Urology: a trip into metaverse 161
Erratum: Why and how to evaluate chronic prostatic inflammation (European Urology (2013) 12:SUPPL. (110-5)) 160
PET/MRI in prostate cancer: a systematic review and meta-analysis 159
Perioperative and Functional Results for Robot-assisted Radical Cystectomy with Totally Intracorporeal Neobladder in Male Patients via the Vesica Patavina (Ves.Pa.) Technique: IDEAL Stage 2a Report 159
Vaginal cuff recurrence after radical cystectomy: an under - studied site of bladder cancer relapse 159
Re: Marlon Perera, Nathan Papa, Daniel Christidis, et al. Sensitivity, Specificity, and Predictors of Positive68Ga Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:926–37 159
THE WAR IS OPENED: PSMA VS. 64CuCL2 VS. CHOLINE PET/CT 159
Abbreviated Versus Multiparametric Prostate MRI in Active Surveillance for Prostate-Cancer Patients: Comparison of Accuracy and Clinical Utility as a Decisional Tool 158
Neutrophil-to-lymphocyte ratio as a prognostic factor for patients with urothelial carcinoma of the bladder following radical cystectomy 158
RETROGRADE INTRA RENAL SURGERY (RIRS) FOR RENAL STONES 158
The future of choline pet in the era of PMSA 156
PD12-12 COMPLICATION RATES AFTER RADICAL CYSTECTOMY AFTER RADIOTHERAPY: AN INTERNATIONAL, MULTICENTER RETROSPECTIVE STUDY ON 609 CASES 156
Natural History of Clinical Recurrence Patterns of Lymph Node-Positive Prostate Cancer after Radical Prostatectomy 155
Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study 154
Adjuvant radiation therapy or observation with or without early salvage radiation therapy for men with node positive prostate cancer after surgery and negative pre-operative conventional imaging: a multicenter study 154
CLINICAL EVOLUTION OF THE RENAL COLIC. AN OBSERVATIONAL STUDY 154
PSMA PET-targeted Biopsy for Prostate Cancer Diagnosis: Initial Experience From a Multicenter Cohort 153
MP57-13 LAPAROSCOPIC VERSUS PERCUTANEOUS CRYOABLATION FOR T1 RENAL MASSES: AN ITALIAN MULTICENTRIC STUDY 152
Observation With or Without Subsequent Salvage Therapy for Pathologically Node-positive Prostate Cancer With Negative Conventional Imaging: Results From a Large Multicenter Cohort 150
Follow-up on patients with initial negative mpMRI target and systematic biopsy for PI-RADS ≥ 3 lesions - an EAU-YAU study enhancing prostate cancer detection 150
Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy: A Systematic Review and Meta-analysis of Prospective Studies 150
Polimorfismi dei geni KLK3, RASA1 e NAALADL2: rischio di cancro alla prostata, aggressività della neoplasia e livelli sierici dell’Antigene Prostatico-Specifico 148
The Future of Choline PET in the Era of Prostate Specific Membrane Antigen 146
Totale 19.784
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.284
article - articoli 78.729
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 278
Totale 161.291
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021323 0 0 0 0 0 0 0 0 0 0 104 219
2021/20221.556 45 183 162 87 66 158 127 132 68 76 119 333
2022/20231.091 238 82 20 112 157 137 26 66 120 10 87 36
2023/20241.022 43 106 98 64 58 85 80 64 58 131 118 117
2024/20254.123 24 315 164 166 462 130 130 364 390 199 665 1.114
2025/202618.274 833 1.575 2.627 3.159 1.725 827 2.370 1.691 1.801 1.178 488 0
Totale 30.030